Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gfi1
|
ENSMUSG00000029275.11 | growth factor independent 1 transcription repressor |
Gfi1b
|
ENSMUSG00000026815.8 | growth factor independent 1B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_107722835_107723098 | Gfi1 | 1377 | 0.277090 | -0.40 | 1.6e-03 | Click! |
chr5_107723149_107724482 | Gfi1 | 528 | 0.608636 | -0.36 | 5.4e-03 | Click! |
chr5_107720809_107722057 | Gfi1 | 2910 | 0.157831 | 0.31 | 1.6e-02 | Click! |
chr5_107724563_107727169 | Gfi1 | 61 | 0.884895 | -0.27 | 3.4e-02 | Click! |
chr5_107722172_107722323 | Gfi1 | 2096 | 0.194861 | -0.27 | 3.6e-02 | Click! |
chr2_28620746_28622145 | Gfi1b | 500 | 0.676351 | -0.93 | 1.1e-26 | Click! |
chr2_28619027_28619457 | Gfi1b | 2703 | 0.160120 | -0.91 | 6.3e-24 | Click! |
chr2_28618712_28618960 | Gfi1b | 3109 | 0.147129 | -0.91 | 7.4e-24 | Click! |
chr2_28619735_28619886 | Gfi1b | 2135 | 0.190200 | -0.86 | 1.6e-18 | Click! |
chr2_28617102_28617454 | Gfi1b | 1873 | 0.209955 | -0.85 | 2.0e-17 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_9269280_9270516 | 40.06 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr18_69595622_69596635 | 25.12 |
Tcf4 |
transcription factor 4 |
1946 |
0.44 |
chr4_110285468_110287125 | 24.91 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr1_42700819_42701404 | 24.70 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
5343 |
0.14 |
chr13_83721518_83722206 | 23.73 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
481 |
0.73 |
chr4_91380440_91381612 | 21.60 |
Elavl2 |
ELAV like RNA binding protein 1 |
4530 |
0.22 |
chr4_49842278_49843034 | 21.24 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chr10_92163758_92164191 | 20.87 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr12_29529828_29531185 | 19.64 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr10_18470218_18471289 | 19.28 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr17_91092075_91093120 | 19.05 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr2_42652202_42653456 | 18.61 |
Lrp1b |
low density lipoprotein-related protein 1B |
97 |
0.98 |
chr12_29528407_29529244 | 18.52 |
Myt1l |
myelin transcription factor 1-like |
424 |
0.85 |
chr7_51623529_51624502 | 17.51 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr4_109155589_109157355 | 17.37 |
Osbpl9 |
oxysterol binding protein-like 9 |
138 |
0.97 |
chr11_34315414_34316667 | 17.34 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr12_46814495_46815083 | 16.90 |
Nova1 |
NOVA alternative splicing regulator 1 |
2171 |
0.31 |
chr15_48791303_48792616 | 16.75 |
Csmd3 |
CUB and Sushi multiple domains 3 |
26 |
0.99 |
chr1_143640264_143641520 | 16.58 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr18_72349127_72350542 | 16.48 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr9_41582824_41584205 | 16.31 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr1_42691569_42692627 | 16.30 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
995 |
0.42 |
chr18_50034808_50035376 | 16.06 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
4063 |
0.24 |
chr6_55680133_55680881 | 15.97 |
Neurod6 |
neurogenic differentiation 6 |
756 |
0.69 |
chr15_100983335_100984381 | 15.83 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
13736 |
0.18 |
chr9_91378153_91379783 | 15.80 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chr9_96731522_96733329 | 15.64 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
244 |
0.91 |
chr13_83716978_83717166 | 15.34 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
4309 |
0.15 |
chr18_69597107_69597709 | 15.08 |
Tcf4 |
transcription factor 4 |
2128 |
0.42 |
chr4_36952312_36953412 | 15.06 |
Gm12371 |
predicted gene 12371 |
104 |
0.95 |
chr14_124675118_124677112 | 15.05 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr12_27337801_27337952 | 15.00 |
Sox11 |
SRY (sex determining region Y)-box 11 |
4698 |
0.32 |
chr18_69350551_69351104 | 14.85 |
Tcf4 |
transcription factor 4 |
1883 |
0.45 |
chr4_110285249_110285423 | 14.82 |
Elavl4 |
ELAV like RNA binding protein 4 |
1280 |
0.61 |
chr1_19212595_19213625 | 14.79 |
Tfap2b |
transcription factor AP-2 beta |
769 |
0.67 |
chrX_100769299_100769740 | 14.66 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
1524 |
0.34 |
chr4_102254418_102255744 | 14.61 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
78 |
0.99 |
chr10_12614437_12615357 | 14.41 |
Utrn |
utrophin |
66 |
0.99 |
chr1_25830818_25831017 | 14.23 |
Gm9884 |
predicted gene 9884 |
260 |
0.82 |
chr9_55025536_55026292 | 14.17 |
Chrna3 |
cholinergic receptor, nicotinic, alpha polypeptide 3 |
616 |
0.61 |
chr2_65566848_65567533 | 13.80 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
302 |
0.92 |
chr16_85170785_85171474 | 13.72 |
Gm27295 |
predicted gene, 27295 |
2280 |
0.26 |
chr4_5645693_5646152 | 13.71 |
Fam110b |
family with sequence similarity 110, member B |
1687 |
0.36 |
chr2_121805962_121806292 | 13.46 |
Frmd5 |
FERM domain containing 5 |
745 |
0.66 |
chr1_106174865_106175693 | 13.42 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
3527 |
0.22 |
chr2_4154106_4154733 | 13.38 |
Frmd4a |
FERM domain containing 4A |
1547 |
0.26 |
chr13_51566607_51568077 | 13.34 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
258 |
0.94 |
chr10_21882056_21883261 | 13.31 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
289 |
0.9 |
chr8_41052368_41053980 | 13.23 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr6_8512108_8512867 | 13.22 |
Glcci1 |
glucocorticoid induced transcript 1 |
1260 |
0.37 |
chr9_10903843_10905236 | 13.09 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr18_37178155_37179152 | 13.09 |
Gm10544 |
predicted gene 10544 |
131 |
0.94 |
chr18_64890376_64890890 | 13.07 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
140 |
0.95 |
chr3_102010214_102010759 | 12.99 |
Nhlh2 |
nescient helix loop helix 2 |
331 |
0.89 |
chr5_19907724_19909563 | 12.80 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
682 |
0.82 |
chr9_52145956_52147029 | 12.78 |
Zc3h12c |
zinc finger CCCH type containing 12C |
21619 |
0.17 |
chr16_23227054_23227205 | 12.77 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
1108 |
0.32 |
chr9_71895330_71895742 | 12.73 |
Tcf12 |
transcription factor 12 |
449 |
0.72 |
chr3_76075315_76075943 | 12.70 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chr12_68996734_68997089 | 12.52 |
Gm47515 |
predicted gene, 47515 |
1941 |
0.32 |
chr5_49284738_49286021 | 12.52 |
Kcnip4 |
Kv channel interacting protein 4 |
280 |
0.92 |
chrX_134405492_134405850 | 12.51 |
Drp2 |
dystrophin related protein 2 |
869 |
0.59 |
chr6_54564534_54565307 | 12.49 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr3_54157562_54157856 | 12.47 |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
1094 |
0.64 |
chr6_92480350_92481798 | 12.46 |
Prickle2 |
prickle planar cell polarity protein 2 |
318 |
0.93 |
chr13_20473087_20474265 | 12.44 |
Gm32036 |
predicted gene, 32036 |
186 |
0.89 |
chr16_16558986_16560577 | 12.43 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr12_15811126_15812067 | 12.36 |
Trib2 |
tribbles pseudokinase 2 |
5189 |
0.17 |
chr8_54954519_54955779 | 12.31 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr5_88583963_88584847 | 12.23 |
Rufy3 |
RUN and FYVE domain containing 3 |
611 |
0.7 |
chr4_82499658_82501360 | 12.23 |
Nfib |
nuclear factor I/B |
1193 |
0.5 |
chr1_184441074_184441672 | 12.20 |
2900092O11Rik |
RIKEN cDNA 2900092O11 gene |
1607 |
0.43 |
chr3_73056547_73057799 | 12.17 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
230 |
0.93 |
chr12_107997791_107998940 | 12.17 |
Bcl11b |
B cell leukemia/lymphoma 11B |
5049 |
0.31 |
chr15_25415436_25415919 | 12.16 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr1_169747005_169748207 | 12.09 |
Rgs4 |
regulator of G-protein signaling 4 |
17 |
0.98 |
chr10_69705909_69707430 | 12.08 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr14_69029360_69030437 | 12.07 |
Gm41192 |
predicted gene, 41192 |
246 |
0.8 |
chr1_66321652_66322390 | 12.04 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr18_40256495_40257230 | 12.00 |
Kctd16 |
potassium channel tetramerisation domain containing 16 |
100 |
0.96 |
chr3_30649995_30651146 | 11.99 |
Lrriq4 |
leucine-rich repeats and IQ motif containing 4 |
2684 |
0.17 |
chr18_22345719_22346098 | 11.90 |
Asxl3 |
additional sex combs like 3, transcriptional regulator |
819 |
0.78 |
chr3_34652462_34653573 | 11.78 |
Sox2 |
SRY (sex determining region Y)-box 2 |
2612 |
0.16 |
chr5_9723538_9723989 | 11.57 |
Grm3 |
glutamate receptor, metabotropic 3 |
1407 |
0.48 |
chr6_28133524_28134506 | 11.56 |
Grm8 |
glutamate receptor, metabotropic 8 |
370 |
0.89 |
chr13_99512095_99512261 | 11.50 |
Map1b |
microtubule-associated protein 1B |
4340 |
0.18 |
chr3_8665551_8665702 | 11.47 |
Hey1 |
hairy/enhancer-of-split related with YRPW motif 1 |
999 |
0.46 |
chr13_78177509_78178575 | 11.46 |
Gm38604 |
predicted gene, 38604 |
5117 |
0.14 |
chr7_79501250_79502506 | 11.45 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr5_65130636_65132102 | 11.44 |
Klhl5 |
kelch-like 5 |
34 |
0.97 |
chrX_103185752_103186844 | 11.42 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
342 |
0.83 |
chr7_94042433_94043470 | 11.42 |
Gm32647 |
predicted gene, 32647 |
199 |
0.97 |
chr7_73376866_73377306 | 11.38 |
A730056A06Rik |
RIKEN cDNA A730056A06 gene |
1312 |
0.3 |
chrX_6050063_6050239 | 11.36 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
2698 |
0.2 |
chr12_61525659_61526870 | 11.35 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2316 |
0.3 |
chrX_152643367_152644550 | 11.30 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr5_13401983_13403185 | 11.26 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
3007 |
0.34 |
chr1_189341351_189342108 | 11.12 |
Kcnk2 |
potassium channel, subfamily K, member 2 |
1626 |
0.32 |
chr2_32536076_32537655 | 11.12 |
Fam102a |
family with sequence similarity 102, member A |
1132 |
0.3 |
chr5_138275220_138276850 | 11.02 |
Gpc2 |
glypican 2 (cerebroglycan) |
2202 |
0.11 |
chr8_22757309_22759411 | 11.00 |
Plat |
plasminogen activator, tissue |
565 |
0.71 |
chr2_181155937_181157234 | 10.99 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr13_97248475_97250229 | 10.91 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr3_79144294_79146166 | 10.88 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
253 |
0.94 |
chr9_59033803_59034249 | 10.87 |
Neo1 |
neogenin |
2399 |
0.36 |
chr3_34656299_34657721 | 10.86 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
974 |
0.4 |
chr1_84709872_84710637 | 10.85 |
Dner |
delta/notch-like EGF repeat containing |
14033 |
0.15 |
chrX_6169933_6171264 | 10.85 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
2417 |
0.31 |
chr1_89071242_89071687 | 10.75 |
Sh3bp4 |
SH3-domain binding protein 4 |
1011 |
0.53 |
chr4_99572683_99573583 | 10.74 |
Gm12690 |
predicted gene 12690 |
3633 |
0.2 |
chr17_3610552_3611747 | 10.70 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53280 |
0.12 |
chr6_83185720_83187846 | 10.69 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr1_132541040_132543287 | 10.67 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr8_113847926_113849082 | 10.66 |
Adamts18 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
111 |
0.98 |
chr2_129698961_129700174 | 10.66 |
Pdyn |
prodynorphin |
266 |
0.93 |
chr6_13837266_13838183 | 10.63 |
Gpr85 |
G protein-coupled receptor 85 |
483 |
0.82 |
chr13_83726534_83727321 | 10.61 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr14_65423052_65425451 | 10.54 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr1_138836757_138837880 | 10.47 |
Lhx9 |
LIM homeobox protein 9 |
3659 |
0.19 |
chr15_25415052_25415352 | 10.45 |
Gm48957 |
predicted gene, 48957 |
139 |
0.9 |
chr17_35700709_35702577 | 10.45 |
Ddr1 |
discoidin domain receptor family, member 1 |
321 |
0.72 |
chr11_50826812_50827037 | 10.44 |
Zfp354c |
zinc finger protein 354C |
466 |
0.69 |
chr19_14594521_14595178 | 10.44 |
Tle4 |
transducin-like enhancer of split 4 |
690 |
0.79 |
chr10_73821409_73822534 | 10.31 |
Pcdh15 |
protocadherin 15 |
28 |
0.99 |
chr14_122472255_122473599 | 10.31 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
652 |
0.55 |
chr13_39823362_39824744 | 10.31 |
A230103O09Rik |
RIKEN cDNA A230103O09 gene |
301 |
0.89 |
chr18_57785762_57786717 | 10.30 |
Gm19519 |
predicted gene, 19519 |
6094 |
0.27 |
chr3_17793835_17795104 | 10.28 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr7_140080531_140082545 | 10.22 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr7_83549180_83550259 | 10.22 |
Gm10610 |
predicted gene 10610 |
537 |
0.76 |
chr18_77564268_77564635 | 10.17 |
Rnf165 |
ring finger protein 165 |
158 |
0.96 |
chr17_90087597_90088717 | 10.17 |
Nrxn1 |
neurexin I |
17 |
0.99 |
chr13_67728554_67729691 | 10.16 |
Zfp65 |
zinc finger protein 65 |
51 |
0.6 |
chr11_68383417_68384056 | 10.13 |
Ntn1 |
netrin 1 |
3090 |
0.29 |
chr18_55733467_55734301 | 10.13 |
Gm26959 |
predicted gene, 26959 |
12344 |
0.27 |
chr5_107498769_107499247 | 10.10 |
Btbd8 |
BTB (POZ) domain containing 8 |
1229 |
0.33 |
chr14_105333345_105334016 | 10.09 |
Ndfip2 |
Nedd4 family interacting protein 2 |
39134 |
0.13 |
chrX_153725037_153725713 | 10.05 |
Nbdy |
negative regulator of P-body association |
458 |
0.73 |
chr16_7040547_7041141 | 10.02 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
29002 |
0.27 |
chr9_41376046_41377501 | 10.01 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
212 |
0.93 |
chr13_109442519_109443753 | 9.98 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr4_46990051_46990797 | 9.96 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
1449 |
0.38 |
chr3_88206822_88208169 | 9.94 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr2_92187716_92188153 | 9.88 |
Phf21a |
PHD finger protein 21A |
1469 |
0.36 |
chrX_105390628_105392456 | 9.87 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr3_34658275_34659470 | 9.87 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2836 |
0.15 |
chr1_79580797_79581843 | 9.87 |
Gm37886 |
predicted gene, 37886 |
39714 |
0.15 |
chrX_166344665_166345995 | 9.86 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr3_56181373_56181654 | 9.86 |
Nbea |
neurobeachin |
2188 |
0.32 |
chr14_79768163_79769199 | 9.84 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr10_4709783_4710728 | 9.81 |
Esr1 |
estrogen receptor 1 (alpha) |
100 |
0.98 |
chrX_97072279_97072758 | 9.78 |
Pgr15l |
G protein-coupled receptor 15-like |
78 |
0.98 |
chr2_116056837_116059755 | 9.77 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr4_126779870_126780295 | 9.77 |
Gm12937 |
predicted gene 12937 |
16333 |
0.12 |
chr14_108913558_108914298 | 9.74 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
230 |
0.97 |
chr1_115686481_115687365 | 9.72 |
Cntnap5a |
contactin associated protein-like 5A |
2167 |
0.34 |
chr6_127887234_127888691 | 9.72 |
Tspan11 |
tetraspanin 11 |
190 |
0.93 |
chr4_110281444_110282224 | 9.71 |
Elavl4 |
ELAV like RNA binding protein 4 |
4782 |
0.33 |
chr4_82501450_82502014 | 9.71 |
Nfib |
nuclear factor I/B |
2416 |
0.3 |
chr1_115684558_115685809 | 9.67 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chr6_77978407_77979215 | 9.67 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
739 |
0.71 |
chr15_78117926_78118077 | 9.66 |
A730060N03Rik |
RIKEN cDNA A730060N03 gene |
1705 |
0.27 |
chr7_78577179_78577473 | 9.66 |
Ntrk3 |
neurotrophic tyrosine kinase, receptor, type 3 |
457 |
0.73 |
chr1_6733530_6734383 | 9.64 |
St18 |
suppression of tumorigenicity 18 |
914 |
0.7 |
chr12_41483283_41485192 | 9.59 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr16_67618825_67619284 | 9.56 |
Cadm2 |
cell adhesion molecule 2 |
1439 |
0.51 |
chr8_8658122_8658842 | 9.55 |
Efnb2 |
ephrin B2 |
2757 |
0.13 |
chrX_6091588_6092836 | 9.55 |
Gm26618 |
predicted gene, 26618 |
57 |
0.96 |
chr5_49524106_49524873 | 9.54 |
Kcnip4 |
Kv channel interacting protein 4 |
275 |
0.91 |
chr10_69533610_69535762 | 9.54 |
Ank3 |
ankyrin 3, epithelial |
464 |
0.86 |
chr7_86775491_86776164 | 9.52 |
Folh1 |
folate hydrolase 1 |
19 |
0.98 |
chr9_40821304_40822316 | 9.51 |
Gm48565 |
predicted gene, 48565 |
841 |
0.43 |
chr4_154639076_154640482 | 9.47 |
Prdm16os |
Prdm16 opposite strand transcript |
2203 |
0.2 |
chr7_75644598_75644909 | 9.44 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
568 |
0.76 |
chr3_55785698_55785971 | 9.43 |
Nbea |
neurobeachin |
1068 |
0.52 |
chr3_107101641_107102643 | 9.43 |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
540 |
0.71 |
chr14_66865047_66865736 | 9.41 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr4_126779227_126779591 | 9.39 |
Gm12937 |
predicted gene 12937 |
17006 |
0.12 |
chr1_66322405_66322814 | 9.39 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr1_42703141_42704653 | 9.38 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr15_20448699_20449797 | 9.38 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chr11_36676450_36677161 | 9.37 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr12_11882344_11882726 | 9.37 |
Tubb2a-ps2 |
tubulin, beta 2a, pseudogene 2 |
128 |
0.97 |
chr12_86681553_86682494 | 9.36 |
Vash1 |
vasohibin 1 |
3323 |
0.18 |
chr17_17448568_17449744 | 9.36 |
Lix1 |
limb and CNS expressed 1 |
336 |
0.88 |
chr10_57784547_57786586 | 9.32 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr7_92984620_92985508 | 9.31 |
Gm31663 |
predicted gene, 31663 |
3012 |
0.25 |
chr9_26805533_26806430 | 9.30 |
Glb1l2 |
galactosidase, beta 1-like 2 |
440 |
0.83 |
chr18_65582281_65582868 | 9.30 |
Zfp532 |
zinc finger protein 532 |
39 |
0.95 |
chr1_185332200_185332932 | 9.28 |
Bpnt1 |
bisphosphate 3'-nucleotidase 1 |
359 |
0.73 |
chr9_83663941_83664341 | 9.27 |
Gm36120 |
predicted gene, 36120 |
23384 |
0.17 |
chr3_134236641_134237783 | 9.27 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr16_10446425_10446612 | 9.26 |
Tvp23a |
trans-golgi network vesicle protein 23A |
626 |
0.68 |
chrX_84076569_84077653 | 9.23 |
Dmd |
dystrophin, muscular dystrophy |
462 |
0.87 |
chr13_93309269_93309831 | 9.21 |
Homer1 |
homer scaffolding protein 1 |
1516 |
0.3 |
chr11_61453075_61454398 | 9.21 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr2_90886739_90886966 | 9.19 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
992 |
0.36 |
chr12_98577628_98578516 | 9.18 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
238 |
0.9 |
chr6_145075061_145076261 | 9.18 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
523 |
0.72 |
chr18_54720208_54720640 | 9.18 |
Gm5821 |
predicted gene 5821 |
45708 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.3 | 60.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
10.7 | 32.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
9.8 | 68.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
9.7 | 29.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
7.5 | 22.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.8 | 20.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
6.6 | 19.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
6.3 | 25.1 | GO:0061743 | motor learning(GO:0061743) |
6.2 | 18.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
6.1 | 24.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
6.1 | 12.2 | GO:0048880 | sensory system development(GO:0048880) |
6.0 | 18.0 | GO:0021828 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
5.9 | 23.6 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
5.8 | 23.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
5.8 | 17.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
5.7 | 17.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.7 | 17.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
5.6 | 16.9 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
5.5 | 16.6 | GO:0007525 | somatic muscle development(GO:0007525) |
5.5 | 16.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
5.4 | 16.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
5.3 | 26.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.2 | 46.6 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
5.1 | 25.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
5.0 | 20.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.9 | 14.7 | GO:0072017 | distal tubule development(GO:0072017) |
4.7 | 9.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
4.7 | 14.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
4.7 | 14.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
4.6 | 13.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
4.5 | 17.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
4.3 | 12.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
4.3 | 12.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
4.0 | 4.0 | GO:1903367 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
4.0 | 19.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.9 | 27.2 | GO:0097264 | self proteolysis(GO:0097264) |
3.9 | 3.9 | GO:0060594 | mammary gland specification(GO:0060594) |
3.9 | 3.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.8 | 15.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
3.8 | 19.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.7 | 3.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
3.7 | 11.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
3.7 | 11.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
3.6 | 10.8 | GO:0030035 | microspike assembly(GO:0030035) |
3.6 | 39.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
3.5 | 3.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
3.5 | 7.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
3.5 | 21.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
3.5 | 7.0 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
3.5 | 10.5 | GO:0060174 | limb bud formation(GO:0060174) |
3.5 | 10.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
3.5 | 27.8 | GO:0071625 | vocalization behavior(GO:0071625) |
3.5 | 13.8 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
3.4 | 10.2 | GO:0061205 | paramesonephric duct development(GO:0061205) |
3.4 | 6.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.4 | 16.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
3.3 | 6.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.3 | 6.7 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
3.3 | 10.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.3 | 9.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
3.2 | 16.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.2 | 9.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
3.2 | 3.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
3.1 | 31.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.1 | 12.4 | GO:0090427 | activation of meiosis(GO:0090427) |
3.1 | 12.4 | GO:0060278 | regulation of ovulation(GO:0060278) |
3.1 | 27.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
3.1 | 12.3 | GO:0007412 | axon target recognition(GO:0007412) |
3.1 | 6.2 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
3.1 | 24.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.1 | 3.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.0 | 9.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
3.0 | 39.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.0 | 6.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.0 | 26.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
3.0 | 5.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
3.0 | 14.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
3.0 | 5.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.9 | 2.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.9 | 5.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
2.9 | 5.8 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.9 | 2.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.8 | 8.5 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.8 | 8.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.7 | 32.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
2.7 | 5.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.7 | 8.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.6 | 5.3 | GO:0035106 | operant conditioning(GO:0035106) |
2.6 | 5.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.6 | 7.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.6 | 7.9 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
2.6 | 7.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.6 | 5.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.5 | 5.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
2.5 | 2.5 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
2.5 | 12.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.5 | 10.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
2.5 | 20.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.4 | 14.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.4 | 19.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
2.3 | 4.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
2.3 | 4.6 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.3 | 6.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.3 | 13.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.3 | 16.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
2.3 | 130.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.3 | 4.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.3 | 4.5 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
2.2 | 2.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
2.2 | 22.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
2.2 | 2.2 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
2.2 | 4.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.2 | 8.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.2 | 4.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.1 | 6.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.1 | 8.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
2.1 | 17.1 | GO:0050957 | equilibrioception(GO:0050957) |
2.1 | 10.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
2.1 | 2.1 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.1 | 4.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.1 | 4.2 | GO:0007625 | grooming behavior(GO:0007625) |
2.1 | 6.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.1 | 6.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.1 | 6.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.1 | 4.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
2.1 | 6.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.0 | 8.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
2.0 | 8.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.0 | 12.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.0 | 2.0 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
2.0 | 6.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.0 | 18.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
2.0 | 2.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.0 | 2.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
2.0 | 25.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
2.0 | 4.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.0 | 21.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.9 | 42.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.9 | 1.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.9 | 1.9 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.9 | 11.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.9 | 3.8 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.9 | 19.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.9 | 42.0 | GO:0007616 | long-term memory(GO:0007616) |
1.9 | 5.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.9 | 1.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.9 | 9.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
1.8 | 7.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.8 | 9.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 5.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.8 | 7.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.8 | 19.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.8 | 7.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.8 | 1.8 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.8 | 3.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.8 | 7.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.8 | 5.3 | GO:1903416 | response to glycoside(GO:1903416) |
1.8 | 5.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.8 | 5.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.8 | 8.8 | GO:0033762 | response to glucagon(GO:0033762) |
1.7 | 3.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.7 | 3.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.7 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
1.7 | 10.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
1.7 | 1.7 | GO:0021586 | pons maturation(GO:0021586) |
1.7 | 3.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.7 | 5.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.7 | 3.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.7 | 10.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.7 | 5.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.7 | 1.7 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.7 | 8.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.7 | 20.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.7 | 5.0 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.7 | 35.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
1.7 | 5.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.6 | 1.6 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
1.6 | 1.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.6 | 6.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.6 | 9.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.6 | 4.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.6 | 6.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.6 | 1.6 | GO:0021612 | rhombomere 4 development(GO:0021570) facial nerve structural organization(GO:0021612) |
1.6 | 3.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.6 | 9.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
1.6 | 6.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.6 | 1.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.6 | 6.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.6 | 9.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.5 | 4.6 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.5 | 3.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.5 | 109.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.5 | 3.0 | GO:0014028 | notochord formation(GO:0014028) |
1.5 | 1.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.5 | 4.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.5 | 3.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.5 | 14.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.5 | 10.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.5 | 2.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 11.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.5 | 13.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.5 | 2.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.5 | 4.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.5 | 34.8 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
1.4 | 5.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.4 | 103.0 | GO:0007612 | learning(GO:0007612) |
1.4 | 2.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.4 | 61.4 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
1.4 | 1.4 | GO:0003025 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.4 | 2.9 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.4 | 4.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.4 | 4.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.4 | 5.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.4 | 4.3 | GO:0008038 | neuron recognition(GO:0008038) |
1.4 | 1.4 | GO:0071435 | potassium ion export(GO:0071435) |
1.4 | 1.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.4 | 1.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.4 | 8.4 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
1.4 | 9.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.4 | 4.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.4 | 1.4 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.4 | 2.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.4 | 23.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.4 | 2.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.4 | 5.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.4 | 4.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.4 | 4.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.4 | 1.4 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.4 | 2.7 | GO:0061055 | myotome development(GO:0061055) |
1.3 | 2.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.3 | 1.3 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
1.3 | 2.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.3 | 2.7 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.3 | 21.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.3 | 1.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.3 | 3.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.3 | 3.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.3 | 19.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.3 | 2.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.3 | 10.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.3 | 6.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.3 | 5.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
1.3 | 2.5 | GO:0060166 | olfactory pit development(GO:0060166) |
1.3 | 5.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.2 | 1.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.2 | 2.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.2 | 7.4 | GO:0061042 | vascular wound healing(GO:0061042) |
1.2 | 100.2 | GO:0007411 | axon guidance(GO:0007411) |
1.2 | 3.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.2 | 7.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.2 | 4.9 | GO:0035989 | tendon development(GO:0035989) |
1.2 | 4.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.2 | 6.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.2 | 1.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.2 | 2.4 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.2 | 2.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.2 | 2.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.2 | 3.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.2 | 8.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.2 | 17.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.2 | 9.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.2 | 4.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.2 | 3.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.2 | 2.3 | GO:0001757 | somite specification(GO:0001757) |
1.2 | 19.7 | GO:0007416 | synapse assembly(GO:0007416) |
1.2 | 4.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.1 | 3.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.1 | 2.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.1 | 5.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.1 | 2.3 | GO:0001975 | response to amphetamine(GO:0001975) |
1.1 | 3.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
1.1 | 3.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.1 | 12.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
1.1 | 2.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.1 | 2.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.1 | 4.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.1 | 5.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 7.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.1 | 2.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.1 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 2.2 | GO:0003032 | detection of oxygen(GO:0003032) |
1.1 | 5.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.1 | 4.4 | GO:0030091 | protein repair(GO:0030091) |
1.1 | 20.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
1.1 | 1.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.1 | 10.9 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
1.1 | 2.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.1 | 1.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
1.1 | 3.2 | GO:0097503 | sialylation(GO:0097503) |
1.1 | 1.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
1.1 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.0 | 5.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.0 | 10.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.0 | 4.2 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.0 | 3.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.0 | 1.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.0 | 4.1 | GO:0007296 | vitellogenesis(GO:0007296) |
1.0 | 4.1 | GO:0043586 | tongue development(GO:0043586) |
1.0 | 3.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.0 | 7.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.0 | 3.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.0 | 2.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.0 | 6.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.0 | 8.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.0 | 3.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.0 | 3.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.0 | 2.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.0 | 2.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 1.9 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.0 | 1.0 | GO:0033483 | gas homeostasis(GO:0033483) |
1.0 | 1.0 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.0 | 1.9 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.0 | 2.9 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
1.0 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.0 | 1.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.9 | 9.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.9 | 1.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.9 | 6.6 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.9 | 0.9 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.9 | 20.6 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.9 | 15.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.9 | 24.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 3.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 0.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.9 | 0.9 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.9 | 5.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.9 | 2.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.9 | 4.5 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.9 | 4.5 | GO:0021794 | thalamus development(GO:0021794) |
0.9 | 3.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.9 | 4.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.9 | 0.9 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.9 | 2.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 2.7 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.9 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.9 | 3.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.9 | 4.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 3.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.9 | 0.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.9 | 3.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.9 | 2.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 2.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 3.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 0.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.8 | 9.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.8 | 5.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.8 | 2.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.8 | 8.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.8 | 5.9 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.8 | 3.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 0.8 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.8 | 2.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.8 | 1.7 | GO:0070779 | L-glutamate import(GO:0051938) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 5.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.8 | 2.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 1.7 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.8 | 0.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 0.8 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.8 | 2.5 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.8 | 44.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.8 | 3.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.8 | 1.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.8 | 2.5 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.8 | 1.6 | GO:0060618 | nipple development(GO:0060618) |
0.8 | 2.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 1.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.8 | 0.8 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.8 | 1.6 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.8 | 0.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.8 | 3.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 2.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.8 | 2.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.8 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.8 | 2.3 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.8 | 2.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.8 | 0.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 2.3 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.8 | 2.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.8 | 2.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 0.8 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.8 | 2.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.8 | 0.8 | GO:0048840 | otolith development(GO:0048840) |
0.8 | 9.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.8 | 7.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.8 | 2.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 1.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 12.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.7 | 3.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.7 | 3.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 0.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.7 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.7 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 2.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 2.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.7 | 3.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 2.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 3.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 1.4 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.7 | 2.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.7 | 5.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.7 | 5.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 4.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.7 | 6.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.7 | 4.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.7 | 5.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.7 | 2.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.7 | 1.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 2.8 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 4.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 11.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.7 | 0.7 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.7 | 1.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.7 | 0.7 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.7 | 3.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.7 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.7 | 2.7 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.7 | 5.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.7 | 0.7 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.7 | 12.0 | GO:0050808 | synapse organization(GO:0050808) |
0.7 | 1.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.7 | 4.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.7 | 3.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.7 | 2.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.7 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 0.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 1.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.6 | 1.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.6 | 1.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 1.3 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.6 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 16.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.6 | 0.6 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.6 | 3.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.6 | 1.9 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.6 | 10.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.6 | 1.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 3.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.6 | 5.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.6 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.6 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 0.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.6 | 2.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.6 | 2.5 | GO:0001964 | startle response(GO:0001964) |
0.6 | 0.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.6 | 23.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.6 | 0.6 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.6 | 3.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 1.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 1.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 6.7 | GO:0030901 | midbrain development(GO:0030901) |
0.6 | 1.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.6 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 1.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 10.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 2.4 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.6 | 4.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 1.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 0.6 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.6 | 4.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 1.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.6 | 1.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.6 | 1.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 1.7 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.6 | 1.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.6 | 1.7 | GO:0022038 | corpus callosum development(GO:0022038) |
0.6 | 1.7 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.6 | 1.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.6 | 1.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.6 | 3.9 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.6 | 1.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.6 | 6.2 | GO:0032094 | response to food(GO:0032094) |
0.6 | 5.0 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.6 | 1.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.6 | 3.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 2.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.6 | 1.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.6 | 6.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.6 | 3.3 | GO:0015846 | polyamine transport(GO:0015846) |
0.6 | 1.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 4.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.5 | 2.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 6.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.5 | 1.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 8.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.5 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 0.5 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.5 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.5 | 1.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 4.8 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 0.5 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.5 | 1.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.5 | 7.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.5 | 15.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.5 | 6.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 8.8 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 2.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.5 | 2.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.5 | 1.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.5 | 3.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 1.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.5 | 4.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.5 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 3.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 2.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 3.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 0.5 | GO:0003306 | Wnt signaling pathway involved in heart development(GO:0003306) |
0.5 | 1.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 6.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 24.5 | GO:0071804 | cellular potassium ion transport(GO:0071804) |
0.5 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 1.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 0.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.5 | 1.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 2.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 11.9 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.5 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.5 | 4.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 0.5 | GO:0002125 | maternal aggressive behavior(GO:0002125) cellular response to cocaine(GO:0071314) |
0.5 | 1.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.5 | 1.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 2.8 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.5 | 0.9 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.5 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.5 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 5.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.5 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 3.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 2.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.5 | 1.4 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 0.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.5 | 2.7 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.5 | 1.8 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 5.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 12.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.4 | 0.4 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.4 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 7.1 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.4 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 0.9 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 0.4 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 2.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 6.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.4 | 1.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 0.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 2.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.4 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 2.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 5.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 0.8 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 0.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.4 | 6.6 | GO:0021543 | pallium development(GO:0021543) |
0.4 | 0.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 2.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 0.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 0.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.4 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.4 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 2.0 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.4 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 2.0 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.4 | 7.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 0.8 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 1.2 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 2.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 4.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 0.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 0.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 3.8 | GO:0032402 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.4 | 4.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.4 | 1.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 0.8 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 1.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 0.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 1.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 16.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.4 | 8.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.4 | 2.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.4 | 7.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.4 | 1.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 21.1 | GO:0007409 | axonogenesis(GO:0007409) |
0.4 | 3.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 2.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 0.7 | GO:0030578 | PML body organization(GO:0030578) |
0.3 | 2.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 0.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.3 | 0.3 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
0.3 | 0.7 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.3 | 1.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 1.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.3 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 3.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 9.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.3 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 1.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 2.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 2.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 1.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.3 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 4.8 | GO:0007588 | excretion(GO:0007588) |
0.3 | 0.3 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.9 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 1.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.3 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.3 | 9.9 | GO:0001764 | neuron migration(GO:0001764) |
0.3 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 2.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.3 | GO:0007620 | copulation(GO:0007620) |
0.3 | 6.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 1.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 1.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 0.6 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.3 | 1.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 2.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.3 | 1.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 2.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 0.6 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.3 | 0.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 0.8 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 0.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.3 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.1 | GO:1902475 | ornithine transport(GO:0015822) L-alpha-amino acid transmembrane transport(GO:1902475) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 2.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 1.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.3 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 2.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 2.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 0.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 0.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.3 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 0.3 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.3 | 0.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.5 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 0.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 6.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.2 | 0.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 2.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 1.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 6.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.2 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 7.8 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.2 | 0.2 | GO:0060384 | innervation(GO:0060384) |
0.2 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 6.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.2 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 3.8 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.9 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.2 | 1.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 2.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.7 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 2.8 | GO:0042551 | neuron maturation(GO:0042551) |
0.2 | 0.9 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 1.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.2 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 3.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.6 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 1.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.6 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 1.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.2 | 0.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 2.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 2.7 | GO:0048747 | muscle fiber development(GO:0048747) |
0.2 | 0.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 0.4 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.2 | 0.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.9 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 1.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 1.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 1.5 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
0.2 | 0.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.5 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.3 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.2 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.5 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.8 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 1.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.7 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 1.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 1.3 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.7 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 2.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.1 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.1 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.7 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.7 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.4 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.2 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.3 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.1 | GO:0021537 | telencephalon development(GO:0021537) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.1 | 0.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.2 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 2.2 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.1 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 1.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.1 | GO:1904994 | regulation of leukocyte tethering or rolling(GO:1903236) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.2 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.0 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:1901301 | cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.0 | 0.0 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.0 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.0 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.0 | 0.0 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.4 | GO:0016358 | dendrite development(GO:0016358) |
0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.0 | 0.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 49.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.3 | 4.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
4.1 | 24.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
4.1 | 37.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.1 | 20.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.1 | 24.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.1 | 48.6 | GO:0043194 | axon initial segment(GO:0043194) |
4.0 | 59.5 | GO:0031527 | filopodium membrane(GO:0031527) |
3.7 | 11.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.4 | 24.0 | GO:0071437 | invadopodium(GO:0071437) |
3.3 | 19.7 | GO:0032584 | growth cone membrane(GO:0032584) |
3.2 | 16.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
3.2 | 82.8 | GO:0044295 | axonal growth cone(GO:0044295) |
3.2 | 167.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.1 | 21.6 | GO:0043083 | synaptic cleft(GO:0043083) |
2.9 | 2.9 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.7 | 66.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.6 | 23.4 | GO:0005883 | neurofilament(GO:0005883) |
2.5 | 24.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.4 | 7.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 6.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.3 | 6.8 | GO:0097441 | basilar dendrite(GO:0097441) |
2.2 | 6.7 | GO:0097427 | microtubule bundle(GO:0097427) |
2.2 | 6.6 | GO:0033269 | internode region of axon(GO:0033269) |
2.2 | 39.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.2 | 13.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.1 | 2.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 2.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.0 | 3.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.9 | 19.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.8 | 28.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.8 | 44.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.8 | 24.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.7 | 10.1 | GO:0016342 | catenin complex(GO:0016342) |
1.6 | 9.9 | GO:0030673 | axolemma(GO:0030673) |
1.6 | 20.5 | GO:0034704 | calcium channel complex(GO:0034704) |
1.5 | 15.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.5 | 90.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.5 | 41.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.5 | 4.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.4 | 4.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.4 | 9.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 184.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.4 | 5.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.4 | 5.5 | GO:0097433 | dense body(GO:0097433) |
1.4 | 19.1 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 6.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.3 | 9.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.3 | 10.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 2.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 4.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 19.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.2 | 3.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.1 | 2.2 | GO:0097513 | myosin II filament(GO:0097513) |
1.1 | 12.2 | GO:0031045 | dense core granule(GO:0031045) |
1.1 | 9.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 4.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.1 | 4.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 6.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.0 | 6.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
1.0 | 11.0 | GO:0035102 | PRC1 complex(GO:0035102) |
1.0 | 1.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.0 | 2.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 27.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 0.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.9 | 95.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.9 | 7.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 13.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 3.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 2.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.9 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.9 | 7.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.9 | 5.2 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.8 | 31.5 | GO:0030175 | filopodium(GO:0030175) |
0.8 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 6.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.8 | 4.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.7 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 4.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.7 | 2.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 2.2 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 2.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.7 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 7.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 2.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 3.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 5.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 5.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.6 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 87.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 4.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 1.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 5.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.6 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 1.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 2.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 48.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 0.6 | GO:0034705 | potassium channel complex(GO:0034705) |
0.6 | 5.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.6 | 1.7 | GO:0070160 | occluding junction(GO:0070160) |
0.6 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 3.4 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 4.5 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 0.6 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.5 | 1.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 4.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 8.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.5 | 2.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 3.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 3.0 | GO:0046930 | pore complex(GO:0046930) |
0.5 | 33.1 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 1.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 11.0 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 14.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.5 | 115.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.5 | 1.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 0.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.4 | 1.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 23.0 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 3.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 3.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 11.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 26.4 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 1.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 13.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 2.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 22.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 2.3 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 0.7 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 4.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 18.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 58.4 | GO:0030425 | dendrite(GO:0030425) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 6.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 20.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 9.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 2.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 2.5 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 2.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 4.8 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 5.6 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 0.9 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 0.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 36.5 | GO:0045202 | synapse(GO:0045202) |
0.3 | 0.5 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.3 | 11.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 5.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 2.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 73.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 10.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.2 | 2.7 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 6.6 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 3.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 1.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 1.1 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 6.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 2.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 39.3 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 1.5 | GO:0031674 | I band(GO:0031674) |
0.2 | 1.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 4.0 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 7.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 5.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 20.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.7 | GO:0005882 | intermediate filament(GO:0005882) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 49.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
12.3 | 24.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
10.2 | 30.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
10.0 | 49.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
7.9 | 70.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
6.3 | 18.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
5.6 | 16.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.5 | 22.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.4 | 21.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
5.3 | 16.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.0 | 20.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
5.0 | 34.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
5.0 | 14.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
4.6 | 22.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
4.6 | 13.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.2 | 12.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
4.2 | 24.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
4.1 | 16.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
4.0 | 12.1 | GO:0035939 | microsatellite binding(GO:0035939) |
3.9 | 11.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.9 | 19.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
3.7 | 14.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
3.6 | 24.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
3.4 | 10.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.4 | 20.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
3.4 | 13.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.4 | 27.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
3.3 | 13.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.1 | 9.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
3.1 | 9.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
2.9 | 5.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.9 | 17.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.9 | 14.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.8 | 5.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
2.8 | 19.5 | GO:0003680 | AT DNA binding(GO:0003680) |
2.7 | 11.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.7 | 8.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.7 | 5.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.6 | 7.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.6 | 7.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.6 | 7.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.5 | 7.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.4 | 12.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.3 | 9.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.3 | 4.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.2 | 8.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
2.2 | 19.7 | GO:0038191 | neuropilin binding(GO:0038191) |
2.2 | 10.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
2.1 | 49.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
2.0 | 8.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 22.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
2.0 | 10.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.0 | 60.1 | GO:0045296 | cadherin binding(GO:0045296) |
2.0 | 9.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.0 | 29.4 | GO:0031402 | sodium ion binding(GO:0031402) |
1.9 | 5.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.9 | 3.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.9 | 5.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.9 | 9.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.9 | 3.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.9 | 35.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.9 | 43.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.9 | 46.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.8 | 11.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.8 | 3.6 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.8 | 5.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.8 | 5.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.8 | 5.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.8 | 17.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.7 | 29.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.7 | 12.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.7 | 16.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.6 | 6.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.6 | 1.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.6 | 8.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.6 | 4.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.6 | 4.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.6 | 56.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.5 | 1.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.5 | 31.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.5 | 4.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.5 | 14.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.5 | 7.3 | GO:0048495 | Roundabout binding(GO:0048495) |
1.5 | 23.3 | GO:0015026 | coreceptor activity(GO:0015026) |
1.5 | 16.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.4 | 24.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.4 | 8.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
1.4 | 1.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.4 | 8.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.4 | 5.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.4 | 5.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 35.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.3 | 49.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.3 | 2.7 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.3 | 36.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.3 | 5.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.3 | 6.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.3 | 15.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.3 | 2.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.3 | 6.6 | GO:0045545 | syndecan binding(GO:0045545) |
1.3 | 3.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.3 | 3.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 5.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.3 | 3.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.3 | 5.1 | GO:0031433 | telethonin binding(GO:0031433) |
1.3 | 12.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.3 | 1.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 2.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.3 | 2.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 8.5 | GO:0036122 | BMP binding(GO:0036122) |
1.2 | 4.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
1.2 | 33.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.2 | 1.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.2 | 3.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 5.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.2 | 13.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.1 | 13.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.1 | 10.0 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 2.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.1 | 11.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.1 | 6.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 4.3 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
1.1 | 14.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.1 | 3.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.1 | 8.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 11.5 | GO:0015643 | toxic substance binding(GO:0015643) |
1.0 | 9.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.0 | 1.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.0 | 6.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.0 | 3.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.0 | 5.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.0 | 18.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.0 | 28.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.0 | 8.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.0 | 10.0 | GO:0051378 | serotonin binding(GO:0051378) |
1.0 | 18.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.0 | 4.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.0 | 3.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.0 | 12.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 3.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.0 | 3.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.0 | 4.8 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
1.0 | 3.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 1.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.9 | 16.9 | GO:0005112 | Notch binding(GO:0005112) |
0.9 | 11.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.9 | 14.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.9 | 4.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.9 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 2.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.9 | 4.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 5.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.9 | 0.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.9 | 3.5 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.9 | 7.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 14.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.9 | 6.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.9 | 3.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 3.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 4.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.8 | 1.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 11.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.8 | 4.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.8 | 2.4 | GO:0018568 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.8 | 3.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.8 | 6.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.8 | 34.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.8 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 2.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 9.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.8 | 15.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.8 | 0.8 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.8 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 2.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.8 | 4.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 5.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.8 | 3.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 2.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.8 | 2.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 3.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 18.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.7 | 4.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 17.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.7 | 5.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 11.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 3.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 3.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.7 | 4.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 5.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 10.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.7 | 2.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 1.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 1.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.7 | 1.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.7 | 2.6 | GO:0033265 | choline binding(GO:0033265) |
0.7 | 0.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.7 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 3.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 2.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 11.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 10.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.6 | 5.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.6 | 3.2 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 24.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.6 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.6 | 2.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 3.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 3.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 1.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 3.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 3.6 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.6 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.6 | 2.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 5.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 9.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.6 | 4.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 6.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.6 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 13.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.6 | 3.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.6 | 5.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.6 | 3.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 0.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 1.1 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 2.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 9.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.5 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.5 | 4.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 21.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 2.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 10.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 3.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 7.9 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.5 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 9.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 2.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.5 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 1.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 4.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.5 | 1.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 7.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 2.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 3.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 1.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 12.0 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 7.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 2.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 11.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 7.9 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.4 | 8.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.4 | 1.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 0.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 5.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 36.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 1.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 1.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 2.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.4 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 1.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 0.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.4 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 0.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.7 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.4 | 4.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 1.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 0.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 19.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 3.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 1.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 1.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 0.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 7.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 14.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 5.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 9.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 0.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 2.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 7.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 7.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.3 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.3 | 2.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 5.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 6.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 3.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 2.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 8.1 | GO:0005267 | potassium channel activity(GO:0005267) |
0.3 | 3.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.6 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 3.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.9 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 2.8 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 2.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 3.9 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 29.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 64.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 120.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 176.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.3 | 0.9 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 4.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.3 | 2.8 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 6.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 2.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 0.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 2.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.8 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.3 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 7.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 14.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 4.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 65.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.7 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 4.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 5.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 3.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 2.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.0 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.4 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 1.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 12.0 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 5.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 3.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 2.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 4.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 17.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 6.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 1.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.1 | GO:0034859 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 1.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 5.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 2.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.8 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.1 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 3.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 9.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 58.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.7 | 125.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.4 | 37.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.3 | 18.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.2 | 58.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.2 | 31.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.2 | 22.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.1 | 23.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 15.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 10.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.0 | 6.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 11.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.0 | 15.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 9.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 6.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 13.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 7.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.8 | 17.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 24.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 38.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.7 | 21.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 17.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 30.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.7 | 16.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 8.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 5.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 7.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.6 | 12.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 4.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 9.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 17.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.6 | 76.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 80.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 1.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.5 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 13.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 2.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 9.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 6.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 3.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 6.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 2.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 5.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 6.6 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 1.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 4.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 4.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 6.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 2.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 5.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 8.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 4.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 8.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 2.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 43.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 10.9 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 43.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
4.6 | 119.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
3.6 | 65.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.1 | 34.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
2.7 | 54.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.6 | 39.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.3 | 32.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.2 | 30.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.1 | 2.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
2.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.0 | 48.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 20.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.7 | 33.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.4 | 55.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.4 | 32.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.4 | 29.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.4 | 15.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.4 | 1.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.3 | 14.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.2 | 50.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 26.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.2 | 15.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 2.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.1 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
1.0 | 18.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.0 | 2.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.0 | 12.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.0 | 1.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.9 | 6.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 10.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 17.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.9 | 19.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.9 | 8.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.9 | 15.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 13.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.8 | 8.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.8 | 19.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 4.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.8 | 0.8 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.8 | 1.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.8 | 49.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.7 | 20.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 11.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 13.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 3.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 6.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 3.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 7.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 1.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 8.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 10.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 5.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 1.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 91.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 3.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 21.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 9.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 19.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 12.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 13.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 4.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 16.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.5 | 5.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 5.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 1.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.5 | 5.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 2.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 7.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 5.1 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.4 | 5.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 9.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 2.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 3.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 2.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 2.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.4 | 14.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 5.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 4.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 2.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 3.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 11.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 1.6 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 6.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 4.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 2.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 4.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 4.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 4.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |